These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16472148)
21. Cilostazol, not aspirin, reduces ischemic brain injury via endothelial protection in spontaneously hypertensive rats. Oyama N; Yagita Y; Kawamura M; Sugiyama Y; Terasaki Y; Omura-Matsuoka E; Sasaki T; Kitagawa K Stroke; 2011 Sep; 42(9):2571-7. PubMed ID: 21799161 [TBL] [Abstract][Full Text] [Related]
22. Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damage. Nonaka Y; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H Neurosci Lett; 2009 Mar; 452(2):156-61. PubMed ID: 19383431 [TBL] [Abstract][Full Text] [Related]
23. Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats. Park SY; Lee JH; Kim CD; Rhim BY; Hong KW; Lee WS Brain Res; 2007 Jul; 1157():112-20. PubMed ID: 17521620 [TBL] [Abstract][Full Text] [Related]
24. Effect of cilostazol, a selective type-III phosphodiesterase inhibitor, on water-immersion stress-induced gastric mucosal injury in rats. Ohba R; Otaka M; Odashima M; Jin M; Komatsu K; Konishi N; Wada I; Horikawa Y; Matsuhashi T; Oyake J; Hatakeyama N; Watanabe S J Gastroenterol; 2006 Jan; 41(1):34-40. PubMed ID: 16501855 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells. Kim KY; Shin HK; Choi JM; Hong KW J Pharmacol Exp Ther; 2002 Feb; 300(2):709-15. PubMed ID: 11805237 [TBL] [Abstract][Full Text] [Related]
26. Cilostazol attenuates gray and white matter damage in a rodent model of focal cerebral ischemia. Honda F; Imai H; Ishikawa M; Kubota C; Shimizu T; Fukunaga M; Saito N Stroke; 2006 Jan; 37(1):223-8. PubMed ID: 16339464 [TBL] [Abstract][Full Text] [Related]
27. Cilostazol enhances integrin-dependent homing of progenitor cells by activation of cAMP-dependent protein kinase in synergy with Epac1. Lee DH; Lee HR; Shin HK; Park SY; Hong KW; Kim EK; Bae SS; Lee WS; Rhim BY; Kim CD J Neurosci Res; 2011 May; 89(5):650-60. PubMed ID: 21337364 [TBL] [Abstract][Full Text] [Related]
28. Cilostazol, a cyclic AMP phosphodiesterase inhibitor, stimulates nitric oxide production and sodium potassium adenosine triphosphatase activity in SH-SY5Y human neuroblastoma cells. Inada H; Shindo H; Tawata M; Onaya T Life Sci; 1999; 65(13):1413-22. PubMed ID: 10503960 [TBL] [Abstract][Full Text] [Related]
29. Protection from apoptotic cell death by cilostazol, phosphodiesterase type III inhibitor, via cAMP-dependent protein kinase activation. Kim MJ; Lee JH; Park SY; Hong KW; Kim CD; Kim KY; Lee WS Pharmacol Res; 2006 Oct; 54(4):261-7. PubMed ID: 16822680 [TBL] [Abstract][Full Text] [Related]
30. Cilostazol preserves CA1 hippocampus and enhances generation of immature neuroblasts in dentate gyrus after transient forebrain ischemia in rats. Lee JH; Shin HK; Park SY; Kim CD; Lee WS; Hong KW Exp Neurol; 2009 Jan; 215(1):87-94. PubMed ID: 18938164 [TBL] [Abstract][Full Text] [Related]
31. Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells. Ota H; Eto M; Kano MR; Ogawa S; Iijima K; Akishita M; Ouchi Y Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1634-9. PubMed ID: 18556572 [TBL] [Abstract][Full Text] [Related]
32. Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats. Lee JH; Park SY; Lee WS; Hong KW Neurol Res; 2005 Jul; 27(5):483-92. PubMed ID: 15978173 [TBL] [Abstract][Full Text] [Related]
33. Cilostazol, an inhibitor of type 3 phosphodiesterase, stimulates large-conductance, calcium-activated potassium channels in pituitary GH3 cells and pheochromocytoma PC12 cells. Wu SN; Liu SI; Huang MH Endocrinology; 2004 Mar; 145(3):1175-84. PubMed ID: 14645120 [TBL] [Abstract][Full Text] [Related]
34. Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia. Kwon KJ; Lee EJ; Kim MK; Kim SY; Kim JN; Kim JO; Kim HJ; Kim HY; Han JS; Shin CY; Han SH Neurobiol Dis; 2015 Jan; 73():12-23. PubMed ID: 25281785 [TBL] [Abstract][Full Text] [Related]
35. Neuroprotection of Cilostazol against ischemia/reperfusion-induced cognitive deficits through inhibiting JNK3/caspase-3 by enhancing Akt1. Qi DS; Tao JH; Zhang LQ; Li M; Wang M; Qu R; Zhang SC; Liu P; Liu F; Miu JC; Ma JY; Mei XY; Zhang F Brain Res; 2016 Dec; 1653():67-74. PubMed ID: 27769787 [TBL] [Abstract][Full Text] [Related]
36. Cilostazol: treatment of intermittent claudication. Reilly MP; Mohler ER Ann Pharmacother; 2001 Jan; 35(1):48-56. PubMed ID: 11197586 [TBL] [Abstract][Full Text] [Related]
37. Cilostazol: a review of its use in intermittent claudication. Chapman TM; Goa KL Am J Cardiovasc Drugs; 2003; 3(2):117-38. PubMed ID: 14727939 [TBL] [Abstract][Full Text] [Related]
38. Cilostazol protects rat chondrocytes against nitric oxide-induced apoptosis in vitro and prevents cartilage destruction in a rat model of osteoarthritis. Lee SW; Song YS; Shin SH; Kim KT; Park YC; Park BS; Yun I; Kim K; Lee SY; Chung WT; Lee HJ; Yoo YH Arthritis Rheum; 2008 Mar; 58(3):790-800. PubMed ID: 18311796 [TBL] [Abstract][Full Text] [Related]
39. Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats--an MRI study. Lee JH; Lee YK; Ishikawa M; Koga K; Fukunaga M; Miyakoda G; Mori T; Hosokawa T; Hong KW Brain Res; 2003 Dec; 994(1):91-8. PubMed ID: 14642452 [TBL] [Abstract][Full Text] [Related]